ADVERTISEMENT
Search

From the Desk of the CEO

Empowering Pharmacy Voices, Inspiring Change

Discover insights, stories, and expertise from pharmacists shaping the future of healthcare. Explore thought-provoking discussions, industry trends, and personal experiences that define the pharmacy profession.

Posted: Sep 14, 2021

Federal government makes two announcements with major pharmacy implications in 24 hours

September 9, 2021, was a busy day for the federal government and pharmacy stakeholders alike: Just a few hours apart, we saw significant developments in pharmacists’ COVID-19 pandemic practice authorities and prescription drug pricing. Both items yielded positive news for pharmacists and their patients.

Read more
Posted: Sep 10, 2021

Non-Hispanic Black and Mexican-American adults diagnosed with diabetes at a younger age

New findings published in JAMA Network revealed that non-Hispanic Black and Mexican-American adults were diagnosed with diabetes at a younger age—typically 4 to 7 years earlier—than non-Hispanic whites. 

Read more
Posted: Sep 7, 2021

North Dakota, which once lost its fight to regulate PBM practices, gets a rematch

At the U.S. Eighth Circuit Court of Appeals last week, Pharmaceutical Care Management Association (PCMA) and North Dakota delivered oral arguments in litigation over state laws regulating some PBM practices. The proceedings were the latest step in PCMA v Wehbi’s winding path through the courts. The circuit court once sided with the PBM lobbying group, but the U.S. Supreme Court vacated that ruling after it unanimously decided to uphold an Arkansas PBM-regulation law.

Read more
Posted: Sep 7, 2021

Tocilizumab in short supply due to pandemic

Some individuals with rheumatoid arthritis (RA) are treated with a monthly infusion of the biologic tocilizumab (Actemra—Genentech). However, the drug is now in short supply because of the surge in COVID-19 cases.

Read more
Posted: Sep 3, 2021

CDC releases guidance on caring for ‘COVID long-haulers’

Thousands of patients have reported experiencing a wide range of physical and mental health consequences that persist after a COVID-19 infection. Patients with post-COVID-19 conditions, sometimes referred to as “COVID long-haulers,” often experience issues four or more weeks after being infected with the virus. Many of these patients routinely seek medical treatment for relief of their symptoms.

Read more
First34568101112Last
Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT